Please try another search
For the six months ended 30 June 2013, Fusion PharmInc revenues decreased 39% to $502K. Net income decreased94% to $25K. Revenues reflect a decrease in demand for theCompany's products and services due to unfavorable marketconditions. Net income also reflects Depreciation increaseof 30% to $18K (expense). Basic Earnings per Shareexcluding Extraordinary Items decreased from $0.16 to$0.01.
Period Ending: | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Jun 30, 2012 |
---|---|---|---|---|
Total Revenue | 0.33 | 48.81 | 8.2 | 33.56 |
Gross Profit | 0.15 | 17.38 | 1.06 | 13.61 |
Operating Income | 0.02 | 4.77 | -0.03 | 0.9 |
Net Income | 0.02 | 4.38 | 0.8 | -0.3 |
Period Ending: | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Jun 30, 2012 |
---|---|---|---|---|
Total Assets | 0.63 | 104.6 | 53.17 | 99.06 |
Total Liabilities | 0.36 | 38.32 | 13.5 | 35.17 |
Total Equity | 0.28 | 66.28 | 39.67 | 63.89 |
Period Ending: | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Jun 30, 2012 |
---|---|---|---|---|
Period Length: | 6 Months | 0 Months | 12 Months | 6 Months |
Cash From Operating Activities | -0.02 | 6.15 | 2.01 | -5.41 |
Cash From Investing Activities | 0.01 | -5.68 | 0 | -1.29 |
Cash From Financing Activities | 0.01 | -1.84 | 0 | 7.54 |
Net Change in Cash | 0 | -1.79 | 2.01 | 1.39 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review